NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.64
-0.16 (-1.16%)
At close: Jan 16, 2026, 4:00 PM EST
13.64
0.00 (0.00%)
After-hours: Jan 16, 2026, 4:04 PM EST
NovoCure Stock Forecast
Stock Price Forecast
The 6 analysts that cover NovoCure stock have a consensus rating of "Buy" and an average price target of $26.42, which forecasts a 93.70% increase in the stock price over the next year. The lowest target is $14.5 and the highest is $39.
Price Target: $26.42 (+93.70%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Reiterates $18 | Hold | Reiterates | $18 | +31.96% | Jan 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $39 | Strong Buy | Maintains | $42 → $39 | +185.92% | Jan 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $42 | Strong Buy | Maintains | $38 → $42 | +207.92% | Oct 30, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $25 → $23 | Hold | Maintains | $25 → $23 | +68.62% | Oct 27, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $40 → $15 | Buy → Hold | Downgrades | $40 → $15 | +6.30% | Jul 25, 2025 |
Financial Forecast
Revenue This Year
663.81M
from 605.22M
Increased by 9.68%
Revenue Next Year
703.84M
from 663.81M
Increased by 6.03%
EPS This Year
-1.41
from -1.56
EPS Next Year
-1.52
from -1.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 696.2M | 775.9M | ||
| Avg | 663.8M | 703.8M | ||
| Low | 626.5M | 645.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.0% | 16.9% | ||
| Avg | 9.7% | 6.0% | ||
| Low | 3.5% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.38 | -1.25 | ||||
| Avg | -1.41 | -1.52 | ||||
| Low | -1.47 | -1.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.